@article{article, title  = {{A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/j.ejca.2023.113455 }},

 year = {{2023}},

 month = {{11}},

 author = {{Dayimu A and Gupta A and Matin RN and Nobes J and Board R and Payne M and Rao A and Fusi A and Danson S and Eccles B and Carser J et al}},

 doi = {{10.1016/j.ejca.2023.113455}},

 volume = {{196}},

 journal = {{European Journal of Cancer}},

 pages = {{113455-113455}},

 note = {{Accessed on 2025/01/03}}}